Sitryx

Sitryx Therapeutics

The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Dualyx

This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.

Promakhos

This company develops oral small-molecule immunotherapies that restore immune system function to treat patients with chronic inflammatory diseases.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

Matchpoint Therapeutics

This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.